Enrofloxacin Market |
Enrofloxacin, or
1-Cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, is a fluoroquinolone antibiotic used to treat bacterial infections. Baytril,
the trade name of enrofloxacin, is indicated for the control, in chickens, of
mortality associated with Escherichia coli. The U.S FDA approved the use of
enrofloxacin in 1996 to treat certain bacterial infections in poultry. The drug
has low minimal inhibitory concentrations (MICs) and favorable pharmacokinetic
properties. It has been approved by the European Food Safety Authority for the
treatment of bacterial infections in cattle. It is also an effective antibiotic
that is well tolerated by animals. Its mechanism of action is distinct and it
shows profound bactericidal activity. It has not been used for humans in this
capacity.
There is a high variation of bioavailability
after oral
administration of enrofloxacin between polygastric and monogastric animals
from 10% to 80%. Among animals, cats and dogs have the highest susceptibility
to bacterial infection. A dosage of 11.5 mg/kg twice a day is safe for a
healthy cat or dog. When given to a cat or dog, it should be given to him on an
empty stomach. It can be administered along with a small food or treat. It is
important not to give dairy products or antacids with enrofloxacin. The drug is also safe to use in cattle. However, in
these animals, it is illegal to administer the medication.
Despite its effectiveness against a wide
range of bacteria, Enrofloxacin has
only been approved for use against Pseudomonas spp. Most of the time, it is
used as a last resort when first-line drugs fail to treat the infection. There
are several side effects of the drug, but it is safe and does not cause severe
adverse reactions. Moreover, enrofloxacin does not produce permanent side
effects and is not addictive.
Enrofloxacin has been linked to new microbes
resisting antibiotics, both in animals and in humans. The FDA bans the use of an
antibiotic in animals, citing a threat to human health. In 2005, the agency decided
to ban the use of the antibiotic enrofloxacin (Baytril) in poultry.
Comments
Post a Comment